FundaMental Pharma Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $13.8M

  • Investors
  • 5

FundaMental Pharma General Information

Description

Developer of neurological drugs designed to address neurodegeneration in the brain. The company offers drugs that uncouple the physiological function of glutamate-gated NMDA receptors from their toxic effects, abolishing extrasynaptic NMDARs-induced glutamate neurotoxicity while preserving the effects of synaptic NMDARs on neuronal survival and memory, providing a means of stopping neurodegeneration, restoring function, and maintaining brain health, enabling patients affected by neurodegenerative diseases to maintain brain health and improve overall well-being.

Contact Information

Website
www.fundamentalpharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Nikola-Tesla-Straße 1
  • 69124 Heidelberg
  • Germany
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
HealthTech, Life Sciences
Corporate Office
  • Nikola-Tesla-Straße 1
  • 69124 Heidelberg
  • Germany

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FundaMental Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 11-Apr-2024 $13.8M Completed Pre-Clinical Trials
To view FundaMental Pharma’s complete valuation and funding history, request access »

FundaMental Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of neurological drugs designed to address neurodegeneration in the brain. The company offers drugs that uncoup
Drug Discovery
Heidelberg, Germany
10 As of 2024

Dusseldorf, Germany
 

Wendelsheim, Germany
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FundaMental Pharma Competitors (3)

One of FundaMental Pharma’s 3 competitors is Priavoid, a Venture Capital-Backed company based in Dusseldorf, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Priavoid Venture Capital-Backed Dusseldorf, Germany
Modag Venture Capital-Backed Wendelsheim, Germany
Axon Neuroscience Formerly VC-backed Larnaca, Cyprus
You’re viewing 3 of 3 competitors. Get the full list »

FundaMental Pharma Patents

  • 24

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 10

    Pending

  • Expiring in next 12 mo

FundaMental Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026175524-A1 Arylcyclobutylamines and other modulators of nmda receptor-mediated toxicity Pending 24-Feb-2025
WO-2026176121-A1 Arylcyclobutylamines and other modulators of nmda receptor-mediated toxicity Pending 24-Feb-2025
WO-2024223617-A1 Effective means to modulate nmda receptor-mediated toxicity Inactive 24-Apr-2023
AU-2023257613-A1 Effective means to modulate nmda receptor-mediated toxicity Pending 22-Apr-2022
EP-4511355-A2 Effective means to modulate nmda receptor-mediated toxicity Pending 22-Apr-2022 C07C211/29
To view FundaMental Pharma’s complete patent history, request access »

FundaMental Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FundaMental Pharma Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioGeneration Ventures Venture Capital Minority
Coparion Venture Capital Minority
High-Tech Gründerfonds Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
Thuja Capital Management Venture Capital Minority
To view FundaMental Pharma’s complete investors history, request access »

Ready to get started?

Request a free trial

FundaMental Pharma FAQs

  • When was FundaMental Pharma founded?

    FundaMental Pharma was founded in 2016.

  • Where is FundaMental Pharma headquartered?

    FundaMental Pharma is headquartered in Heidelberg, Germany.

  • What is the size of FundaMental Pharma?

    FundaMental Pharma has 10 total employees.

  • What industry is FundaMental Pharma in?

    FundaMental Pharma’s primary industry is Drug Discovery.

  • Is FundaMental Pharma a private or public company?

    FundaMental Pharma is a Private company.

  • What is FundaMental Pharma’s current revenue?

    The current revenue for FundaMental Pharma is .

  • How much funding has FundaMental Pharma raised over time?

    FundaMental Pharma has raised $13.8M.

  • Who are FundaMental Pharma’s investors?

    BioGeneration Ventures, Coparion, High-Tech Gründerfonds, Novartis Venture Fund, and Thuja Capital Management have invested in FundaMental Pharma.

  • Who are FundaMental Pharma’s competitors?

    Priavoid, Modag, and Axon Neuroscience are competitors of FundaMental Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process